Predictors of premature discontinuation of treatment in multiple disease states
about
Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.What Matters to Women When Making Decisions About Breast Cancer Chemoprevention?Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorderFactors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancerLong-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study.Illness perceptions and burden of disease in fibromyalgia.Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?Adherence to 5-alpha reductase inhibitor therapy for benign prostatic hyperplasia: clinical and economic outcomes.A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder.Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?
P2860
Q31141332-FDBDBF25-417A-4636-A3E5-A0786A99D58AQ33910927-D9F14D83-792F-435E-A14F-AF3A095B0F2FQ34675188-C85BBF9D-2C79-4C83-8801-A3BFD284F1E7Q35205431-A0A33A27-C3BD-49D6-873F-1DC33684E074Q37308001-D05AF381-A452-4492-B4C8-A5FE2E0AA8D7Q38425063-E89FDF2E-D288-4B88-8766-371D15DFC819Q38558687-30005EEC-8DFF-4B0A-BEAF-83A69A1C7E64Q38652570-30AA47C5-91FA-47F7-A32F-C33E5E16ACC1Q42078804-390F45A2-B400-416A-A3FD-2D179001FDFAQ48386112-A73671FB-90F7-4382-9FC6-C37093EB6551Q48659349-F80DF27D-0A5E-4724-8512-3724096235F7
P2860
Predictors of premature discontinuation of treatment in multiple disease states
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Predictors of premature discontinuation of treatment in multiple disease states
@en
Predictors of premature discontinuation of treatment in multiple disease states.
@nl
type
label
Predictors of premature discontinuation of treatment in multiple disease states
@en
Predictors of premature discontinuation of treatment in multiple disease states.
@nl
prefLabel
Predictors of premature discontinuation of treatment in multiple disease states
@en
Predictors of premature discontinuation of treatment in multiple disease states.
@nl
P2093
P2860
P356
P1476
Predictors of premature discontinuation of treatment in multiple disease states
@en
P2093
Eric Nantz
Hong Liu-Seifert
Vladimir Skljarevski
P2860
P356
10.2147/PPA.S4633
P407
P577
2009-11-03T00:00:00Z